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Abstract
Background: The latent membrane protein 1 (LMP1) encoded by EBV is expressed in the majority of EBV-associated human
malignancies and has been suggested to be one of the major oncogenic factors in EBV-mediated carcinogenesis. In
previous studies we experimentally demonstrated that down-regulation of LMP1 expression by DNAzymes could increase
radiosensitivity both in cells and in a xenograft NPC model in mice.
Results: In this study we explored the molecular mechanisms underlying the radiosensitization caused by the down-
regulation of LMP1 in nasopharyngeal carcinoma. It was confirmed that LMP1 could up-regulate ATM expression in NPCs.
Bioinformatic analysis of the ATM ptomoter region revealed three tentative binding sites for NF-kB. By using a specific
inhibitor of NF-kB signaling and the dominant negative mutant of IkappaB, it was shown that the ATM expression in CNE1-
LMP1 cells could be efficiently suppressed. Inhibition of LMP1 expression by the DNAzyme led to attenuation of the NF-kB
DNA binding activity. We further showed that the silence of ATM expression by ATM-targeted siRNA could enhance the
radiosensitivity in LMP1 positive NPC cells.
Conclusions: Together, our results indicate that ATM expression can be regulated by LMP1 via the NF-kB pathways through
direct promoter binding, which resulted in the change of radiosensitivity in NPCs.
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Introduction
Radio-resistance has been one of the impediments in clinical
settings for effective cancer therapy, which is thought to be
associated with multiple signaling pathways in different cancer
types. ATM (ataxia telangiectasia mutated) is a nuclear 350-kDa
protein kinase with a carboxylterminal phosphatidylinositol 3-
kinase-like kinase domain [1]. It functions as a member of a
coordinated system that detects DNA breaks; arrests the cells
temporarily at G1, S, or G2 checkpoints; and activates DNA
repair [2]. Cells lacking functional ATM protein show increased
sensitivity to ionizing radiation (IR) and other genotoxic events
[3,4,5]. NF-kB (nuclear factor kappa B) can activate a great
number of genes involved in stress responses, inflammation, and
programmed cell death (apoptosis) [6]. P50 homodimers or p50/
p65 or p50/c-Rel heterodimers bind to the NF-kB DNA binding
sites in the promoter regions of many stress-responsive genes,
suggesting a complex gene and physiological regulation network
controlled by NF-kB in stress response [7]. The elevated basal NF-
kB activity in certain cancers has been linked to tumor resistance
to chemotherapy and radiation [8]. Inhibition of NF-kB blocked
the adaptive radioresistance [9]. Human breast cancer cells treated
with fractional c-irradiation displayed an enhanced clonogenic
survival and NF-kB activation [10,11]. Thus, it is logical to
speculate that there could be a link between the ATM expression
and NF-kB signaling, yet to be experimentally proven.
LMP1 (Latent Membrane Protein 1) is an Epstein–Barr virus
encoded oncogenic protein composed of a short intracellular N
terminus, six hydrophobic transmembrane domains, and an
intracellular C terminus including three functional domains,
CTAR1, CTAR2, and CTAR3. LMP1 activates its target genes
via different signaling pathways that include NF-kB, JNK/c-Jun/
AP-1, p38-MAPK/ATF, and JAK/STAT [12,13,14,15,16,17].
Activation of NF-kB by LMP1 has been linked to the upregulation
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phosphorothioate-modified ‘‘10–23’’ DNAzymes specifically tar-
geted at the LMP1 mRNA could significantly down-regulate the
expression of LMP1 in a nasopharyngeal carcinoma cell (NPC) and
affected the down-stream pathways activated by LMP1, including
the NF-kB pathway [18,19]. It was also demonstrated that
suppression of the LMP1 expression by the LMP1-targeted
DNAzyme DZ1 could enhance radiosensitivity both in vivo and
vitro [19]. To explore the molecular mechanism of the LMP1-
DNAzyme mediated radiosensitization, bioinformatic analysis
revealed there were three putative NF-kB binding sites in the
ATM promoter region. Thus, we hypothesize that ATM expression
can be regulated by LMP1 through the NF-kB pathways, which
resulted in the change of radiosensitivity in NPCs. In the present
study, we showed that LMP1 indeed activated ATM expression
through the NF-kB pathway and inhibition of LMP1 expression by
the DNAzyme attenuated the binding of the NF-kB transcription
factor to the ATM promoter. Further evidence showed that the
radiosensitivity was recovered when ATM expression was knocked
down by siRNA in NPCs. Thus, the present studies support our
hypothesis and provide further evidence for the use of LMP1-
targeted DNAzymes as potential radiosensitizers for treatment of
the EBV-associated carcinomas.
Methods and Materials
Cell lines and cell culture
CNE1 is a LMP1 negative and low differentiated nasopharyn-
geal squamous carcinoma cell line. The CNE1-LMP1 cell line
constitutively expresses Epstein-Barr virus latent member protein-
1(LMP1) and exhibits accelerated cell proliferation [20]. HNE2 is
a EBV-LMP1-negative human nasopharyngeal carcinoma (NPC)
cell line, HNE2-LMP1 is a cell line constantly expressing LMP1
after the introduction of full-length LMP1 cDNA into HNE2 cells
[21]. HNE2-LMP1-DNMIkBa is a cell line constantly expressing
dominant-negative mutant of IkBa (DNMIkBa) that had a
deletion of 71 amino acids at the N terminus, which competitively
inhibited the activation of NF-kB [22]. All the cell lines were
grown in RPMI 1640 (GIBCO) supplemented with 10% fetal
bovine serum, 1% glutamine, and 1% antibiotics and cultured at
37uC in a humidified incubator containing 5% CO2. The cells in
logarithmic growth phase were used in all experiments.
Plasmids
pSG5-B-346-LMP1 expresses the full-length LMP1 mRNA (the
gift from Dr. Kenneth M, Lzumi. Brigham And Women’s
Hospital). To construct the ATM-promoter assay plasmid, the
sequence of the full ATM promoter (Genbank accession#
GXP_480587) was amplified from the genomic DNA of CNE1
cells with the forward primer of 59-GGTACCTGCGTGGAG-
GATGGAGAAG-39 and reverse primer of 59- AGATCTA-
GAAGCCGCTGCGTTGCCT-39. The 1233-bp product was
cloned into KpnI and BglII sites of the pGL3 basic luciferase
reporter vector (Promega).The resultant plasmid named pLuc-
ATM. The corresponding mutants were derived from pLuc-ATM
with substituting the sequence +105 CCGGGGAACTCCCTA
+120 to +105 CCGAGAAACGCGCTA +120 (pLuc-ATMmNF1)
and substituting the sequence +225CGGGCTTCCCCT+241 to
+225CGAACTGTCTCT +241 (pLuc-ATMmNF2). Mutations at
both sites were made to generate pLuc-ATMmNF1+2.
DNAzyme and siRNA transfection
Prior to transfection, cells were seeded in 6-well plates overnight.
The DNAzyme/TMP (tetra (4-methylpyridyl) porphyrine) mixtures
were made at a charge ratio of 1 with 2 mM DNAzyme
oligonucleotides as described [18,23]. The mixtures were incubated
for 15 min at room temperature to form the transfection complex.
Cells were rinsed twice with PBS. The transfection mixtures of
either DNAzyme or control oligonucleotide (ODN) were then
added to the cells respectively and incubated at 37uC for 4 h in
5%CO2, followed by the addition of complete medium to the wells
and further incubation for indicated time.
ATM-specific siRNA (sc-29761) and control siRNAs were
purchased from Santa Cruze. siRNAs or a scrambled control
siRNA were transfected into the LMP1-positive cells by using
Lipofectamine 2000 according to the manufacturer’s protocol
(Invitrogen).
NF-kB inhibitor and cell treatments
The specific NF-kB inhibitor Bay11-7082 (Calbiochem) were
prepared as a stock solution of 20 mM in dimethylsulfoxide
(DMSO, Sigma). Subconfluent cells were treated with the
compound at indicated concentrations for the indicated time.
The final concentration of DMSO in the culture media was kept
less than 0.1% which had no significant effect on the cell growth.
Western blot analysis
Cells were harvested and washed twice with ice-cold phosphate-
buffered saline (PBS), and lysed in the lysis buffer [10 mM Tris–
HCl, pH 8.0, 1 mM EDTA, 2% SDS, 5 mM dithiothreitol,
10 mM phenylmethyl sulfonylfluoride, 1 mMNa3VO4, 1 mM
NaF, 10% (vol./vol.) glycerol, protease inhibitor cocktail tablet
(Roche)] for 30 min on ice and then centrifuged at 15,0006g for
10 min. The supernatant was collected as the whole cell lysates.
Protein concentration was determined by BCA Assay Reagent
(Pierce). 100 mg of the total proteins from various cell preparations
and rainbow molecular weight markers (Amersham Pharmacia
Biotech, Amersham, United Kingdom) were separated on SDS
polyacrylamide gel and then electrotransferred onto the nitrocel-
lulose membrane. The membranes were blocked with buffer
containing 5% non-fat milk in PBS with 0.05% Tween-20 for 2 h,
and incubated with different primary antibodies overnight at 4uC.
After second wash, the membranes were incubated with anti-
rabbit (sc-2004, Santa Cruz) or anti-mouse (sc-2005, Santa Cruz)
horseradish peroxidase-conjugated secondary antibody for 1 h at
RT and developed with the enhanced chemiluminescence
detection kit (ECL; Pierce). The following antibodies were used
for Western blotting: mouse LMP1 monoclonal antibody (M0897,
DAKO), ATM (sc-23922, Santa Cruz), p-IkBa against Ser-32 of
p-IkBa (sc-8404, Santa Cruz), IkBa against the C-terminus of
IkBa(sc-371, Santa Cruz), a-tubulin (sc-5286, Santa Cruz), b-actin
(sc-8432, Santa Cruz).
Real-time PCR
Total RNAwas isolated from HNE2 and HNE2-LMP1cellswith
the TRIzol reagent (Invitrogen) according to the manufacturer’s
instructions, followed by cDNA synthesis using the SuperScript
TM
IIRT (Invitrogen). Real-time PCR was performed with Stratagene
Mx3000P (Agilent Technologies, Redwood City, CA, USA) using
SYBR Green qPCR Supermix-UDG universal PCR Master Mix
(Invitrogen). cDNA was subjected to PCR with PCR primers
specific for ATM (sense: 59-CAGCAGCTGTTACCTGTTTG-39
and anti-sense: 59-TAGATAGGCCAGCATTGGAT-39)a n d
LMP1 (sense: 59- TGACTGGACTGGAGGAGC-39 and 59-
AGCGATGAGCAGGAGGGT-39. The reaction was amplified
as follows: 40 cycles of 95uC for 15 s and 60uC for 60 s followed by
an extensionat 72uCfor 10 min. PCRreactionwith porcine b-actin
primers (sense: 59-CACGCCATCCTGCGTCTGGA-39, and an-
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internal control.
Transient Transfections
Subconfluent proliferating CNE1 cells were co-transfected with
increasing amounts of pSG5-B-346-LMP1 LMP1 expressing
plasmid (0, 0.5, 1 ug/well) and decreasing amounts of control
vector pSG5 (1, 0.5, 0 mg/well) using Lipofectamine 2000
(Invitrogen). Twenty four hours after transfection, the cells were
harvested for western blot assay.
Luciferase Assay
The construct (pLuc-ATM) was cotransfected with the pRL-TK
vector (Promega) at a ratio of 10:1 into cells using lipofecta-
mine2000. Twenty four hours after transfection,the cells were
collected and luciferase activity was measured using the Dual
Luciferase Assay (Promega, E1910). Briefly, 100 ml of firefly
luciferase substrate (LARII) and 20 ml of cell extract were mixed,
and the reaction was immediately measured for 10 s. Then 100 ml
of Renilla luciferase substrate including an inhibitor for firefly
luciferase (Stop & Glow) was added, and light emission was
detected for another 10 s interval. The ratio of both measurements
(pGL/pRL) represents the relative luciferase activity.
Bioinformatics analysis
Bioinformatics analysis was performed for the ATM promoter
region (GenBank Accession GXP_480587) and three putative NF-
kB binding sites were found. The first potential NF-kB binding site
was identified at position 107 to 119, on the sense strand (NF1); the
second site at position 290 to 320 (NF2) and the third binding site at
position 108 to 120 (NF3) on the antisense strand. The sequences of
the first and third binding sites were same but on different strands.
Electrophoretic Mobility Shift Assay (EMSA)
The NF-kB EMSA was performed according to manufacturer’s
instructions (Pierce). Briefly, 8610
6 cells were washed in ice-cold
phosphate-buffered saline and the nuclear protein was extracted
with the Nuclear Extract Kit (Active Motif). Protein concentration
was determined by BCA Assay Reagent (Pierce). Two double-
stranded ATM probes corresponding to the NF-kB binding sites in
the ATM promoter region were designed as NF1: 59- GGG-
CCGGGGAACTCCCTATTTGCC -39; NF2: 59- GTGGCGA-
GGGGAAGCCCGAGGGG -39. Approximately 20 fmol of
biotin labeled ATM probes were added to 10 mg of nuclear
extract. The Oct-1 probe containing the sequence 59- TGT-
CGAATGCAAATCACTAGAA-39 was used as a binding control
oligonucleotide. The binding reaction was carried out for 20 min
at room temperature in 10% glycerol, 60 mM KC1, 1 mM
EDTA, 1 mM dithiothreitol, 1 mg/ml poly[dI–dC] and a 200-fold
molar excess of unlabeled competitor oligonucleotide (unlabeled
probe) or mutated oligonucleotides (NF1 or NF2 with mutaions:59-
GGGCCGAGAAACTCCGTATTTGCC -39;59-GTGGCGA-
GAGACAGCCCGAGGGG-39) or nonspecific oligonucleotide.
For supershift experiments, 1 mg of specific anti-p65 or anti-p50 or
anti-p52 antibodies were added to the binding reaction and
incubated for 30 min, after which the biotion-labeled probe was
added. DNA–protein complexes were separated by 5% non-
denaturing polyacrylamide gel.
Irradiation of cells and FACS analysis
Flow cytometry analysis was performed to study the effect of the
ATM-siRNA 6 irradiation (IR) on cellular apoptosis. Cells were
transfected with the ATM-siRNA or Control-siRNA. 48 h later
cells were irradiated with 5 Gy (X ray) and collected for FACS
analysis 72 h after culture. Untreated and treated cells were then
washed with ice-cold PBS and suspended in 75% ethanol at 4uC
overnight. Fixed cells were centrifuged and washed with PBS
twice. Before flow cytometry analysis, cells were stained with
50 mg/ml of PI and 0.1% of RNase A in 400 ml PBS in a light-
proof tube at 25uC for 30 min. Stained cells were assayed on
FACSort (Becton Dickinson) and the cell cycle parameters and the
percentage of apoptotic cells (sub-G1 peak) were determined using
the CellQuest software program (Becton Dickinson).
Colony-forming assay
Colony-forming analysis was performed to study the effect of
the ATM-siRNA or Control-siRNA or DNAzyme (DZ1) or
control oligo (ODN) 6 IR treatment on cell proliferation. Briefly,
LMP1-positive cells CNE1-LMP1 were transfected with ATM-
siRNA or Control-siRNA or DNAzyme (DZ1) or control oligo
(ODN). 48 h later 100, 200 or 1000 cells were seeded into the 6-
well dishes and cultured for another 24 h. These cells were
irradiated with 1 Gy, 2 Gy and 3 Gy X ray, followed by further
culturing for 14 days to allow colonies to form. Colonies (.50
cells) on dishes were visualized by staining with 0.0125% crystal
violet (w/v in 75% ethanol; Sigma–Aldrich, St. Louis, MO).
Plating efficiency was determined as the ratio of the number of
colonies divided by the number of cells seeded. Each data point
represents the mean of three independent experiments. The data
were analyzed using linear-quadratic model [24].
Animal studies
Human nasopharyngeal carcinoma xenograft model in
nude mice. 5610
6 CNE1-LMP1 cells in 0.2 ml of serum-free
RPMI 1640 medium were inoculated s.c. into the right flank of
six-week-old female BALB/c nude mice (6 mice per group).
Tumor volumes were determined according to the formula of
length 6 width 6 height 6 (p/6). When the tumor volume
reached 60–100 mm3, the animals were injected intra-tumourally
with 10 mg of Dz1 or CON with 3 ul FuGene6 (Roche), or saline
alone twice/week in an injectate volume of 20 ml. At the end of the
experiments (day 18 from the first treatment), mice were sacrificed,
tumor tissues stored for histochemical examination. In the groups
where the mice were subjected to irradiation treatment (IR), two
doses of local irradiation at 5 Gy (
60Co) were given 24 h after the
first two DNAzyme injections.
Histology and Immunochemistry
Tumours were removed from euthanized mice and fixed in 4%
neutral formalin at room temperature for 48 h. Serial tissue
sections at 5-mm thick were obtained after embedding in paraffin.
Each slide was stained with haematoxylin and eosin (H&E).
Tissues sections were stained using an anti-LMP1 mAb (DAKO,
Cat#M0897), or NF-kB p65 antibody (Santa Cruz, Cat#8008) at
1:100 or 1: 200 dilution respectively. All sections were examined
by light microscopy (Olympus CX31). The expression of LMP1
and P65 were semi-quantitatively analyzed under a light
microscope at 406magnifications. The total visual areas (A) were
traced randomly and the total areas (B) of the positive cells in the
visual area were determined using an image analyzer (Highspeed
Color Image Analyzer SP500; Olympus, Tokyo, Japan). The
results were expressed as a percentage of B/A (% positive units).
Statistical analyses
All the data were expressed as mean 6 SD. The SFs of each of
the two different treatment cells were compared to the SF for the
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ANOVA. Next, SPSS statistical software version 18.0 was used
to estimate the parameters of the linear-quadratic model. The
statistical difference p,0.05 was considered as significant and
p,0.01 as very significant.
Results
LMP1 enhances ATM expression in human
nasopharyngeal carcinoma cells
To studytheeffectofLMP1onATMexpressioninNPCcells,we
used a constitutely expressing LMP1 cell line CNE1-LMP1,HNE2-
LMP1 and LMP1-negative cell line CNE1,HNE2. We observed
that the ATM expression in LMP1-positive cells was elevated
compared to LMP1-negative cells (Fig. 1A). In order to determine if
the observed increase in ATM expression was related to an effect of
LMP1 at the mRNA level, the ATM expression in CNE1-LMP1
and CNE1 cells were monitored by Real-time PCR. The ATM
mRNA level in CNE1-LMP1 cells was also higher than that in
CNE1 (Fig. 1D). Further to confirm these findings, we transiently
transfectedLMP1-expressingplasmid,pSG5-LMP1,intoCNE1.As
shown in Fig. 1E, the enforced expression of LMP1 in CNE1 cells
also increased the ATM protein level. To investigate the regulatory
effect of LMP1 on ATM expression, we con-transfected CNE1 cells
with an ATM-promoter-luciferase reporter plasmid (pLuc ATM)
and the LMP1-expressing plasmid. The results showed that LMP1
could specifically increase the ATM promoter-controlled luciferase
activity in a dose-dependent manner (Fig. 1G). Therefore, we
conclude that LMP1 could regulate the ATM expression in the
NPC cells and this effect might involve a direct interaction between
LMP1 and the ATM promoter.
Inhibition of LMP1 expression by LMP1-specific
DNAzyme decreases ATM production
In order to validate the regulatory effect of LMP1 on the ATM
expression, we used the LMP1 targeted DNAzyme to down
regulate the LMP1 expression in CNE1-LMP1 and CNE1 cells.
When the CNE1-LMP1 cells were treated with a LMP1-targeted
DNAzyme, the LMP1 expression was down-regulated as expected,
which resulted in the concomitantly decreased level of the ATM
expression. Since ATM is an import gene related with IR response
we irridiated the cells at 5 Gy. The results showed that after
radiation the expression of ATM either in CNE1 or CNE1-LMP1
cells were higher than the cells without radiation. Moreover
LMP1-specific DNAzyme can also downregulate the expression of
ATM under radiation (Fig. 2A).To further confirm the above
observation, we used the ATM-promoter-luciferase reporter
system in CNE1-LMP1 cells and showed that while the LMP1
enhanced the ATM promoter activity, the down-regulation of the
LMP1 expression by the DNAzyme brought the ATM promoter
activity to a basal level (Fig. 2C). This was not observed in CNE1
cells. Together, the observations further confirmed the positive
regulatory effect of LMP1 on the ATM expression.
NF-kB is an important transcription factor which is known to
activate a lots of genes including DNA damage responsive genes. It
has been reported LMP1 can regulate NF-kB expression in vitro.
We want to investigate if LMP1 can regulate NF-kB in vivo. To
demonstrate the expression of the target gene LMP1 was indeed
suppressed in the tumor tissues, immunohistochemical staining
was conducted on the cross-sections of paraffin-embedded
formalin-fixed tissues from different treatment groups. DNAzyme
suppressed the LMP1 expression in these tumors, while immuno-
staining in the control oligo did not differ from saline control
(Fig. 2D). Also to gain if downregulate of LMP1 would influence
NF-kB expression or not, NF-kB expression was examined and the
results showed that NF-kB was reduced in the DNAzyme and
DNAzyme+IR groups in comparison with the saline and control
groups (Fig. 2D). These data suggested LMP1 can regulate NF-kB
expression whether under irridiation or not.
NF-kB binds to ATM promoter and regulates ATM
promoter activity
Next, we examined the mechanism by which LMP1 activates
ATM expression. It has been reported and our data also proved
that LMP1 can activate the NF-kB pathway in NPC cells and up-
regulate a number of related genes [21,25,26]. To elucidate if the
LMP1 regulation of ATM is through the NF-kB pathway, we
performed bioinformatics analysis and found that there were three
putative the NF-kB binding sites in the ATM promoter region
(GenBank Accession GXP_480587), which suggested a possible
involvement of NF-kB in the LMP-1 mediated augment of ATM
expression in NPC cells. The first potential NF-kB binding site was
identified at position 107 to 119, on the sense strand (NF1); the
second site at position 290 to 320 (NF2) and the third binding site
at position 108 to 120 (NF3) on the antisense strand. The
sequences of the first and third binding sites were same but on
different strands. To test whether the NF-kB could bind to the
identified sites within the ATM promoter, EMSA assay was
performed using the synthetic oligonucleotide corresponding to
the consensus NF1 at 107 to 119 bp and NF2 at 290 to 320 bp
within the ATM promoter. Gel shift analysis showed that there
was a difference of NF-kB binding to the ATM promoter in the
presence and absence of the LMP1 expression as tested using the
nuclear extracts from CNE1 and CNE1-LMP1 cells (Fig. 3A and
3C). The Dz1 treatment of CNE1-LMP1 resulted in a much
weaker binding of NF-kB to the ATM promoter (Fig. 3A and 3C).
The specificity of NF-kB binding to the ATM-NF1 and ATM-
NF2 was demonstrated by using a 200-fold excess of unlabeled
nonspecific oligonucleotide and mutated oligonucleotides and the
fact that the use of the unlabeled wild type ATM-NF1 or NF2
oligonucleotides completely competed against the labeled ATM-
NF1 or NF2 (Fig. 3A and 3D). The bands of the Oct1 EMSA
indicated the equal amount of the nuclear extracts was used in the
binding assays. To test which members of NF-kB were involved in
the binding, we used the anti-p50, anti-p65 and anti-p52
antibodies to deplete the corresponding NF-kB members in the
nuclear extracts. It was showed that the treatment with p65 and
p52 did not affect the binding except for p50, suggesting that p50
could be the factor involved in the ATM promoter binding (Fig. 3B
and 3D).
To investigate if the NF-kB binding could regulate ATM
promoter activity in cells, we constructed a series of luciferase
reporter gene constructs driven by the ATM promoter with wild
type and mutated binding sites in the pGL3 basic vector (Fig. 4A).
Luciferase reporter assays showed that individual mutations at
either NF1 (ATMmNF1) or NF2 (ATMmNF2) could decrease the
promoter activity by 30%–20%. The mutations at both NF-kB
sites in ATMmNF1+2 constructs resulted in nearly 62% loss of the
promoter activity in CNE1-LMP1 cells (Fig. 4B). This was not
seen in LMP1 negative CNE1 cells. Together, the data supported
that the ATM promoter activity could be regulated in NPC cells
via a direct NF-kB binding to the promoter region.
LMP1 promotes ATM expression through the NF-kB
pathway
A specific NF-kB inhibitor, Bay11-7082 [27], was used to
investigate if suppression of NF-kB had an impact on the ATM
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PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e24647Figure 1. LMP1 enhances ATM expression in human nasopharyngeal carcinoma cells. A, The expression of ATM and LMP1 in CNE1,CNE1-
LMP1,HNE2,HNE2-LMP1 cells by western blots. B, Expression level of ATM was estimated by densitometry and presented as a ratio to the loading
control b-Actin. C, The expression of LMP1 in CNE1 and CNE1-LMP1 cells by Real-time PCR.D, The expression of ATM in CNE1 and CNE1-LMP1 cells by
Real-time PCR. E, CNE1 cells were transiently transfected with increasing amounts of LMP1-expressing plasmid for 24 h and analyzed by Western blots
for the expression of ATM, LMP1, and b-actin. F, Expression level of each protein was estimated by densitometry and presented as a ratio to the
loading control b-Actin. G, Increasing amounts of LMP1 were cotransfected with pLuc-ATM plasmid into CNE1 cells followed by luciferase assay.
(Values are the means 6 SD of three replicates, *p,0.05 compared with the control cells).
doi:10.1371/journal.pone.0024647.g001
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PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e24647Figure 2. Inhibition LMP1 expression by LMP1-specific DNAzyme decreasing ATM production. A, CNE1 and CNE1-LMP1 cells were grown
in six-well plates and CNE1-LMP1 cells were transfected with DNAzyme (DZ1 at 2 mM), or control oligo(ODN), incubated for 24 h, then irradiated at
5 Gy or not. Total cell were havested 1 h later for Western blot using antibodies targeting LMP1 and ATM, b-actin was used as a loading control. B,
Expression level of each protein was estimated by densitometry and presented as a ratio to the loading control b-Actin. C, Comparison of
transcriptional activation of the ATM promoter in human nasopharyngeal carcinoma cell lines. Transient transfected the constructed plasmid carrying
ATM promoter (pLuc ATM) into CNE1 and CNE1-LMP1 NPC cell lines and the cells were transfected with DNAzyme (DZ1 at 2 mM), or control
oligo(ODN). The luciferase reporter assays were performed as described in Materials and methods. The relative luciferase activity normalized to the
value of Renilla activity. The data represent the mean 6 SD of the three independent experiments performed in triplicate. D, Expression of LMP1 and
NF-kB in tumor tissues with or without IR. Tumors were removed from euthanized mice and fixed in 4% neutral formalin. Tissues sections were
stained using an anti-LMP1 mAb. The expression of LMP-1 was semi-quantitatively analyzed under a light microscope at 406magnifications. The
total visual areas (A) were traced randomly and the total areas (B) of the positive cells in the visual area were determined using an image analyzer. The
results were expressed as a percentage of B/A (% positive units).
doi:10.1371/journal.pone.0024647.g002
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of CNE1-LMP1 cells with the NF-kB specific inhibitor [28]
resulted in a dose-dependent suppression of ATM expression in
CNE1-LMP1 cells (Fig. 5A), which was correlated with a dose-
dependent attenuation of IkBa phosphorylation. The decreasing
level of phospho-IkBa was accompanied by accumulation of IkBa
in cells due to a block of its degradation (Fig. 5C). To further
confirm the above observation, a stable NPC cell line expressing
dominant-negative mutant of IkBa (DNMIkBa) [29] was used to
test the role of NF-kB pathway in regulating ATM expression.
DNMIkBa had a deletion of 71 amino acids at the N terminus of
IkBa, which could competitively inhibit the activation of NF-kB
[30]. DNMIkBa expression could be detected by immunoblotting
with an antibody against a peptide mapping at the C-terminus of
IkBa (Fig. 5E). As shown by Western blotting, the cell line that had
a low level of expression of DNMIkB (HNE2-LMP1-DNMIkBa)
exhibited a marginally decreased level of the ATM expression in
LMP1 positive cells (Fig. 5E). The data revealed that the ATM
expression could be regulated by LMP1 via activation of the NF-
kB signaling pathway.
Figure 3. Assay for NF-kB binding to ATM promoter. A, Biotin-labeled wild type ATM-NF1 was incubated with the nuclear extracts from CNE1
(lane 2), CNE1-LMP1 (lanes 3–6) or CNE1-LMP1 treated with Dz1 (lane 7) and CNE1-LMP1 treated with oligonucleotide control ODN (lane 8). A 200-fold
excess of noncompetitive unlabelled Stat3 oligonucleotide (U, lane 4), unlabeled mutated ATM-NF1 (mut, lane 5) and unlabeled wild-type ATM-NF1
(wt, lane 6) were included in the respective reactions. Oct1 bands served as loading control. B, Biotin-labeled wild type ATM-NF1 was incubated with
the nuclear extracts from CNE1-LMP1 treated with antibodies to p65 (lane 3), p50 (lane 4) and p52 (lane 5). C, Biotin-labeled wild type ATM-NF2 was
incubated with the nuclear extracts from CNE1 (lane 2), CNE1-LMP1 (lanes 3) or CNE1-LMP1 treated with Dz1 (lane 4) and CNE1-LMP1 treated with
oligonucleotide control ODN (lane 5). Unlabeled wild-type ATM-NF2 (wt, lane 6) and unlabeled mutated ATM-NF2 (mut, lane 7) were included in the
respective reactions. Oct1 bands served as loading control. D, Biotin-labeled wild type ATM-NF2 was incubated with the nuclear extracts from CNE1-
LMP1 treated with antibodies to p65 (lane 3), p50 (lane 4) and p52 (lane 5).Oct1 bands served as loading control.
doi:10.1371/journal.pone.0024647.g003
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To provide further evidence for the role of ATM in regulation
of apoptosis in LMP1 positive NPC cells, CNE1-LMP1 cells were
treated with 20 pmol of ATM siRNA or control siRNA. A
reduction in ATM protein levels was detected at 48 h post-
transfection in ATM-siRNA-treated CNE1-LMP1 cells (Fig. 6A).
To examine the effect of ATM down-regulation on radiation-
induced apoptosis, the siRNA-treated CNE1-LMP1 cells were
subjected to an x-ray irradiation. Fig. 6C showed that without
radiation (0 Gy) there was no difference of apoptotic rate among
the ATM-siRNA-treated, control-siRNA-treated and non-treated
CNE1-LMP1 cells. This indicated that ATM loss of function was
not sufficient by itself to elicit an apoptotic response. When
exposed to irradiation at 5 Gy, nearly 60% of the cells treated with
ATM-siRNA underwent apoptosis, while only 20% of cells either
treated with control-siRNA or the untreated were in apoptosis
(Fig. 6C). The LMP1-regulated radiosensitivity was not seen in the
LMP1 negative cell CNE1 (data not shown).
To determine whether inhibition of ATM and LMP1 had any
effect on the cell growth under radiation, the clonogenic assay was
performed. A linear-quadratic (LQ) model, which has been widely
used to analyze the radiation response of cells in the low dose
range (0–3 Gy), was applied to the data generation. The
clonogenic survival curves of the ATM-siRNA and siRNA control
treated cells along with the DNAzyme and ODN treatetd cells
were shown in Figure 6D. The survival fractions after exposure to
a clinically relevant dose of 2 Gy was defined as SF2 to represent
intrinsic radiosensitivity of human tumors. As shown in Table 1,
SF2 for the ATM-siRNA and Control-siRNA cells were
0.25460.006 and 0.46260.020, respectively. SF2 for the DNA-
zyme and ODN cells were 0.21660.009 and 0.44060.003,
respectively. When the dose increased the differences of the
surviving fraction between the two cell populations became wider.
Together, inhibition of ATM expression could lead to an
increased radiosensitivity in LMP1 positive cells.
Discussion
NPC is highly radiosensitive, therefore radiotherapy or
radiotherapy in combination with chemotherapy are the main
treatment strategies. However, both modalities are usually
accompanied with complications and the acquired resistance to
the effects of radiotherapy has emerged as a significant
impediment to the effective NPC therapy. It has been reported
that inhibition of EBV oncoproteins expression including LMP1
enhances the radiosensitivity in EBV-related malignancies both in
vitro and in vivo [19,31]. However, how LMP1 contributes to the
radiosensitivity in NPC is still not clear. It is well known now that
ATM protein is an important regulator in signaling DNA damage
[32]. Gueven et al. found that epidermal growth factor sensitized
lymphoblastoid cells to ionizing radiation and that this was
accompanied with a reduced level of ATM protein [33]. Down-
regulation of ATM protein also sensitizes human prostate cancer
cells resulting in an increase in radiation induced apoptosis [34]. In
this study, we demonstrated that LMP1, which is expressed in over
75% of NPC cases, could up-regulate ATM expression. Increased
level of ATM by LMP1 caused a resistance to irradiation, and
decreased level of ATM by siRNA led to a radiosensitization.
These data suggested that the interaction between LMP1 and
ATM in NPCs may play a critical role in radio-resistance.
Accumulated evidence indicates that the transcription factor
NF-kB plays a critical role in cellular protection against a variety
of genotoxic agents including IR, and inhibition of NF-kB leads to
radiosensitization in radioresistant cancer cells [35]. With micro-
array analysis, Amundson et al. showed that of 1238 human genes,
48 (3.87%) are inducible by a single dose of irradiation.
Interestingly, gene expression profiles of the radioresistant human
keratinocyte cell line HK18-IR demonstrate a specific group of
stress-responsive genes of which 10–25% are linked with NF-kB
activation [35]. Although exact functions of these NF-kB-
associated genes are unknown, they are able to influence cell fate
through regulating cell cycle and DNA damage repairs. Investi-
gation into these NF-kB target genes is important for elucidation
of radiation-induced adaptive resistance. NF-kB was found to be
defective in cells from patients with A-T (ataxia-telangiectasia) who
are highly sensitive to DNA damage induced by IR and UV lights.
Both ATM and NF-kB deficiencies result in increased sensitivity to
DNA double strand breaks. Therefore, identification of the
molecular linkage between the kinase ATM and NF-kB signaling
in tumor response to therapeutic IR will lead to a better
understanding of cellular response to IR, and will promise novel
molecular targets for therapy-associated tumor resistance.
As to the link between LMP1 and ATM in NPCs, we previously
reported that LMP1 could activate different signal transduction
pathways that include nuclear factor kappa B (NF-kB), and caused
various downstream pathological changes in cell proliferation,
anti-apoptosis and metastasis [36,37,38,39]. Several studies
demonstrated a correlation of ATM with NF-kB in cell radio-
resistance [40–41]. In a recent report, a direct interaction between
ATM and NF-kB p65 is detected in the resting cells and this
Figure 4. Reporter gene assay for ATM promoter activity.
A, Illustration of the reporter gene constructs with either wild-type or
mutatedNF-kBbindingsitesinATMpromoterregion.B,luciferaserepoter
assay were performed in CNE1 and CNE1-LMP1 cells transfected with the
wild-type or mutant plasmids. The relative luciferase activity normalized
to the value of Renilla activity. The data represent the mean 6 SD of the
three independent experiments performed in triplicate. *p,0.05,
compared with the wild-type pLuc-ATM transfected CNE1-LMP1 cells.
doi:10.1371/journal.pone.0024647.g004
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treatment. Inhibition of ATM with caffeine, KU-55933, or siRNA
or inhibition of the MEK/ERK pathway can block the LDR-
induced NF-kB activation and eliminate the LDR-induced
survival advantage [42]. Interestingly, a study of new Rel/
NFkappaB regulatory networks showed that NF-kB was involved
in regulation of ATM [43]. Here we showed that the ATM
expression could be regulated by NF-kB via a direct binding to the
ATM promoter and inhibition of NF-kB resulted in reduction of
the ATM level. This transcriptional regulation of ATM by NF-kB
reveals a novel mechanism that links ATM expression to the radio-
resistance in the LMP1 positive NPCs. Thus, it is tempting to
suggest that the acquired radio-resistance in NPCs is caused by
LMP1 activation of NF-kB, which directly binds to the promoter
of the ATM gene and increases the level of ATM expression,
leading to a reduced radiosensitivity.
Figure 5. LMP1 mediated increase in ATM expression through the NF-kB pathway. A, CNE1-LMP1 cells were treated with indicated
concentrations of Bay11-7082 for 12 h. ATM expression in NPC cells were measured by Western blot and b-actin was used as a loading control. B,
Expression level of ATM was estimated by densitometry and presented as a ratio to the loading control b-Actin. C, CNE1-LMP1 cells were treated with
indicated concentrations of Bay11-7082 for 2 h and total cell lysate were subjected to Western blots to measure the levels of P-IkBa and IkBa and a-
tubulin was used as a loading control. D, Expression level of each protein was estimated by densitometry and presented as a ratio to the loading
control b-Actin. E, HNE2, HNE2-LMP1 and HNE2-LMP1 cells expressing DNMIkBa were compared for the LMP1, IkBa, dominant negative IkBa and ATM
expression. b-actin was used as a loading control. F, Expression level of ATM was estimated by densitometry and presented as a ratio to the loading
control b-Actin.
doi:10.1371/journal.pone.0024647.g005
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A, CNE1-LMP1 cells were transfected with ATM-siRNA or Control-siRNA and total cellular protein was extracted 48 h later for Western analysis of the
ATM expression. b-actin served as a loading control. B, Expression level of ATM was estimated by densitometry and presented as a ratio to the
loading control b-Actin. C, CNE1-LMP1 cells were transfected with ATM-siRNA or control siRNA. 48 h later, the cells were irradiated at 0, 5 Gy and then
incubated for 72 h before apoptosis was quantified by FACS. Each data point represents the mean average of three separate determinations, with
S.D. values shown. *p,0.05, compared with the Control-siRNA transfected CNE1-LMP1 cells. D, CNE1-LMP1 cells were either transfected with either
ATMsiRNA or ControlsiRNA or DNAzyme (DZ1), or control oligo(ODN) and 48 h later were exposed to 0, 1, 2 and 3 Gy of IR and then incubated for 2
weeks before fixation, staining and colony counting. Clonogenic assays were performed in triplicates. The curves were fit to the data using the linear-
quadratic model of radiation sensitivity.
doi:10.1371/journal.pone.0024647.g006
Table 1. Analysis of radiosensitivity in ATMsiRNA and DZ1 transfected cells#.
ab SF2 Surviving fraction (Gy)
0G y , 1G y 2G y 3G y
ATMsiRNA 0.02703 0.3284 0.2540 0.9230 0.7010 0.2540 0.0486
60.174* 60.078* 60.006* 60.029 60.070* 60.006* 60.002*
CONsiRNA 0.0209 0.2155 0.4620 0.9370 0.7600 0.4620 0.0783
60.124 60.044 60.020 60.031 60.069 60.020 60.003
DZ1 0.0350 0.3633 0.2167 0.8533 0.6720 0.2167 0.0377
60.003 60.010 60.009 60.022 60.004 60.009 60.001
ODN 0.0260 0.2227 0.4400 0.9500 0.7543 0.4400 0.0717
60.002 60.002 60.003 60.013 60.001 60.003 60.001
#Radiobiological parameters were derived from clonogenic survival experiments. The data were generated by SPSS 18.0 for the best fit curves according to the linear-
quadratic model. a and b are the initial and final slopes of the linear quadratic survival curves. Clonogenic assays were performed in triplicate. Mean colony numbers of
cells relative to plating efficiencies and SE were shown in the table.
*p,0.05, compared with the Control-siRNA transfected CNE1-LMP1 cells (n=3).
p,0.05, compared with the ODN transfected CNE1-LMP1 cells (n=3).
doi:10.1371/journal.pone.0024647.t001
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ATM expression in NPCs, which appear to be in disagreement
with a recent publication [44]. In the study Gruhne et al found
that LMP1 could down-regulate the ATM exprssion in a LMP1-
transefected B-lymphoma line BJAB, suggesting a reduced DNA
repair capacity. However, Bose et al showed that the level of ATM
was reduced in NPC clinical smaples, but this reduction was not
related to LMP1 [45]. While it would be difficult to reconcile all
the differences in relation to the interaction between LMP1 and
ATM, it did indicate a complex regulatory network in different
cancers, in this case, lymphomas and NPCs. In addition, ATM has
been viewed as a tumor suppressor gene that functions at multiple
levels involved in cell proliferation, DNA repair, apoptosis and
radiosensitivity. It is possible that ATM plays different roles
depending on the stages of tumorigenicity and development, and
in response to the therapeutic intervention.
In conclution, LMP1 participates in a number of important
cellular processes, including radio-resistance in NPCs that could be
regulated through the interactions between NF-kB and ATM
molecules. This may present a new strategy for an enhanced
radiotherapy for NPCs by targeting the LMP1 alone or in
combinations with other genes involved in the pathway.
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